Pulmonary hypertension (PH), defined by increased pressure within the pulmonary vasculature, is a hemodynamic and pathophysiologic state present in a wide variety of cardiovascular, respiratory, and systemic diseases. The purpose of this consensus statement is to provide a multidisciplinary approach to guidelines for the diagnosis, classification, treatment, and monitoring of PH in dogs. Comprehensive evaluation including consideration of signalment, clinical signs, echocardiographic parameters, and results of other diagnostic tests supports the diagnosis of PH and allows identification of associated underlying conditions. Dogs with PH can be classified into the following 6 groups: group 1, pulmonary arterial hypertension; group 2, left heart disease; group 3, respiratory disease/hypoxia; group 4, pulmonary emboli/pulmonary thrombi/pulmonary thromboemboli; group 5, parasitic disease (Dirofilaria and Angiostrongylus); and group 6, disorders that are multifactorial or with unclear mechanisms. The approach to treatment of PH focuses on strategies to decrease the risk of progression, complications, or both, recommendations to target underlying diseases or factors contributing to PH, and PH-specific treatments. Dogs with PH should be monitored for improvement, static condition, or progression, and any identified underlying disorder should be addressed and monitored simultaneously.

中文翻译：

---

诊断，分类，治疗和监测犬肺动脉高压的ACVIM共识声明指南。

肺动脉高压（PH）由肺血管内压力升高定义，是多种心血管，呼吸系统疾病和全身性疾病中存在的血液动力学和病理生理状态。该共识性声明的目的是为狗的PH诊断，分类，治疗和监测提供多学科的指导方针。全面的评估包括对信号，临床体征，超声心动图参数以及其他诊断测试结果的考虑，可支持PH的诊断并确定相关的潜在疾病。患有PH的狗可分为以下6组：第1组，肺动脉高压；第二组，左心疾病；第三组，呼吸系统疾病/缺氧；第4组 肺栓子/肺血栓/肺血栓栓塞; 第5组，寄生虫病（Dirofilaria和Angiostrongylus）；第6组是多因素或机制不清楚的疾病。PH的治疗方法侧重于降低进展风险，并发症或同时降低两者的风险的策略，针对潜在疾病或有助于PH的因素以及PH特异性治疗的建议。应监测患有PH的狗的病情改善，静态状况或进展，并同时解决和监测发现的任何潜在疾病。针对潜在影响PH的潜在疾病或因素以及PH特定治疗的建议。应监测患有PH的狗的病情改善，静态状况或进展，并同时解决和监测发现的任何潜在疾病。针对潜在影响PH的潜在疾病或因素以及PH特定治疗的建议。应监测患有PH的狗的病情改善，静态状况或进展，并同时解决和监测发现的任何潜在疾病。